Covered California announced its proposed health plans for next year, and says statewide, rates will increase an average of 9.9%
Combining semaglutide with other glucose-lowering agents (insulin, sulfonylureas) is a documented hypoglycemia risk and belongs strictly under clinical supervision
Important Safety and Realistic Expectations Semaglutide is not FDA-approved for smoking cessation, and PlexusDx does not market compounded semaglutide as a smoking-cessation medication
With just about everyone eager to prescribe semaglutide or tirzepatide these days, its a fair question
Real-world studies also reveal variability in patient experiences
Additionally, many imaging sites with DXA technology do not have or wish to use the additional body composition programming, given staff and time constraints